---
title: "Marco Investment Management LLC Has $17.36 Million Position in UnitedHealth Group Incorporated $UNH"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264978807.md"
description: "Marco Investment Management LLC increased its stake in UnitedHealth Group (NYSE: UNH) by 50.8% in Q2, now holding 55,654 shares valued at $17.36 million. Other institutional investors also adjusted their positions, with Kinsale Capital Group acquiring a new position worth $8.48 million. UnitedHealth Group's stock opened at $324.29, with a market cap of $293.75 billion. The company reported Q3 earnings of $2.92 per share, beating estimates, and announced a quarterly dividend of $2.21, payable on December 16."
datetime: "2025-11-08T11:40:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264978807.md)
  - [en](https://longbridge.com/en/news/264978807.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264978807.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/264978807.md) | [繁體中文](https://longbridge.com/zh-HK/news/264978807.md)


# Marco Investment Management LLC Has $17.36 Million Position in UnitedHealth Group Incorporated $UNH

Marco Investment Management LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 50.8% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 55,654 shares of the healthcare conglomerate's stock after acquiring an additional 18,739 shares during the quarter. UnitedHealth Group comprises about 1.4% of Marco Investment Management LLC's portfolio, making the stock its 22nd biggest holding. Marco Investment Management LLC's holdings in UnitedHealth Group were worth $17,362,000 as of its most recent filing with the SEC.

Get **UnitedHealth Group** alerts:

-   Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy

Several other institutional investors and hedge funds have also bought and sold shares of UNH. Kinsale Capital Group Inc. bought a new position in UnitedHealth Group in the 2nd quarter valued at about $8,480,000. Wedbush Securities Inc. boosted its position in shares of UnitedHealth Group by 52.3% during the 2nd quarter. Wedbush Securities Inc. now owns 27,864 shares of the healthcare conglomerate's stock worth $8,693,000 after acquiring an additional 9,570 shares in the last quarter. Chancellor Financial Group WB LP raised its position in UnitedHealth Group by 4.8% during the second quarter. Chancellor Financial Group WB LP now owns 4,495 shares of the healthcare conglomerate's stock valued at $1,402,000 after purchasing an additional 206 shares in the last quarter. Rovin Capital UT ADV boosted its holdings in shares of UnitedHealth Group by 203.8% in the 2nd quarter. Rovin Capital UT ADV now owns 1,659 shares of the healthcare conglomerate's stock valued at $518,000 after purchasing an additional 1,113 shares in the last quarter. Finally, Cornerstone Investment Partners LLC raised its holdings in shares of UnitedHealth Group by 11.4% during the 2nd quarter. Cornerstone Investment Partners LLC now owns 148,705 shares of the healthcare conglomerate's stock worth $46,391,000 after buying an additional 15,239 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

## UnitedHealth Group Stock Performance

NYSE UNH opened at $324.29 on Friday. The company has a market capitalization of $293.75 billion, a price-to-earnings ratio of 16.93, a PEG ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock has a fifty day simple moving average of $345.84 and a 200 day simple moving average of $323.37. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

-   UnitedHealth Group’s Recovery in Full Swing: Buy While It's Down

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion during the quarter, compared to analysts' expectations of $113.19 billion. During the same quarter in the prior year, the firm posted $7.15 earnings per share. The business's quarterly revenue was up 12.2% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

## UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group's dividend payout ratio is currently 46.14%.

## Analyst Upgrades and Downgrades

-   Big Banks Are Setting the Tone as Earnings Season Kicks Off

A number of research analysts have issued reports on UNH shares. Zacks Research upgraded UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research report on Monday, October 6th. Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Weiss Ratings upgraded shares of UnitedHealth Group from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Friday, October 24th. KeyCorp increased their price target on UnitedHealth Group from $350.00 to $400.00 and gave the company an "overweight" rating in a research note on Wednesday, October 8th. Finally, Bank of America boosted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a "neutral" rating in a research report on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $397.12.

**Read Our Latest Report on UnitedHealth Group**

## UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

## Featured Articles

-   Five stocks we like better than UnitedHealth Group
-   What is the Dogs of the Dow Strategy? Overview and Examples
-   OpenAI's Restructuring Sets up What Could Be the Biggest IPO Ever
-   What is Short Interest? How to Use It
-   2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
-   What is Put Option Volume?
-   CrowdStrike Partners With CoreWeave But Investors Sell the News

_This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._

## Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [UnitedHealth Group Incorporated (UNH.US)](https://longbridge.com/en/quote/UNH.US.md)

## Related News & Research

- [If You Invested $100 In UnitedHealth Group Stock 15 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/280859618.md)
- [A Look At UnitedHealth Group (UNH) Valuation As Avery AI Launch Draws Fresh Attention](https://longbridge.com/en/news/280888247.md)
- [UnitedHealth (UNH) Joins the SCHD Dividend Club after a 45% Drop — Is Smart Money Buying the Dip?](https://longbridge.com/en/news/280938032.md)
- [Morgan Stanley, Blackstone, Allstate And A Health Care Stock On CNBC's 'Final Trades'](https://longbridge.com/en/news/281186109.md)
- [Capital Investment Advisors LLC Has $35.07 Million Position in Honeywell International Inc. $HON](https://longbridge.com/en/news/280868888.md)